Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5Y50

Crystal structure of eukaryotic MATE transporter AtDTX14

Summary for 5Y50
Entry DOI10.2210/pdb5y50/pdb
DescriptorProtein DETOXIFICATION 14 (1 entity in total)
Functional Keywordsalpha helical, membrane protein
Biological sourceArabidopsis thaliana (Mouse-ear cress)
Cellular locationMembrane ; Multi-pass membrane protein : Q9C994
Total number of polymer chains1
Total formula weight49544.00
Authors
Miyauchi, H.,Kusakizako, T.,Nishizawa, T.,Ishitani, R.,Nureki, O. (deposition date: 2017-08-06, release date: 2017-12-06, Last modification date: 2023-11-22)
Primary citationMiyauchi, H.,Moriyama, S.,Kusakizako, T.,Kumazaki, K.,Nakane, T.,Yamashita, K.,Hirata, K.,Dohmae, N.,Nishizawa, T.,Ito, K.,Miyaji, T.,Moriyama, Y.,Ishitani, R.,Nureki, O.
Structural basis for xenobiotic extrusion by eukaryotic MATE transporter
Nat Commun, 8:1633-1633, 2017
Cited by
PubMed Abstract: Mulitidrug and toxic compound extrusion (MATE) family transporters export xenobiotics to maintain cellular homeostasis. The human MATE transporters mediate the excretion of xenobiotics and cationic clinical drugs, whereas some plant MATE transporters are responsible for aluminum tolerance and secondary metabolite transport. Here we report the crystal structure of the eukaryotic MATE transporter from Arabidopsis thaliana, at 2.6 Å resolution. The structure reveals that its carboxy-terminal lobe (C-lobe) contains an extensive hydrogen-bonding network with well-conserved acidic residues, and their importance is demonstrated by the structure-based mutational analysis. The structural and functional analyses suggest that the transport mechanism involves the structural change of transmembrane helix 7, induced by the formation of a hydrogen-bonding network upon the protonation of the conserved acidic residue in the C-lobe. Our findings provide insights into the transport mechanism of eukaryotic MATE transporters, which is important for the improvement of the pharmacokinetics of the clinical drugs.
PubMed: 29158478
DOI: 10.1038/s41467-017-01541-0
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

239492

PDB entries from 2025-07-30

PDB statisticsPDBj update infoContact PDBjnumon